AbbVie invests in switchable CAR-T therapies for cancer

Wednesday, July 25, 2018 - 20:18 in Health & Medicine

The drug company is partnering with Calibr to develop universal CAR T-cells directed to different tumors via antibody switches

Read the whole article on

Get the latest and most popular science news articles of the week in your Inbox! It's free!